Big Token Inc (fka BGTK)

[BIOCHEMUP]

SRAX sounds financially viable through these rough COVID-19 times if you ask me, here are some important tidbits of information from Q2 2020 transcript regarding the FPVD takeover.

we're finding that it's definitely something that is of importance to the market where we think there's a big opportunity for BIGtoken to do something on its own and really be potentially do some kind of strategic positioning and that we're exploring a bunch of things with BIGtoken right now. And I think that'll everybody will learn about some decisions we make about that in the next month and a half to two months

But then as far as the rights go, that would be attributed to the strategic thing that I just mentioned a little bit ago. So from time in the month and a half to two months from now, I think you have a much clearer understanding of what's happening there

What's the status of the SRAX rights expiring on 12/31/2020 and the MD payouts for the $10 million?

So, we still are owed the money, if they sell the business. So, we anticipate that that'll happen on here in the future.

CHA-CHING.

Source: https://www.google.be/amp/s/seekingalpha.com/amp/article/4369354-srax-inc-srax-ceo-chris-miglino-on-q2-2020-results-earnings-call-transcript (08/17/20)